Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial.
机构:[1]Division of Colorectal Surgery, Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China.[2]Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery IV, Peking University Cancer Hospital and Institute, Beijing, China.[3]Department of General Surgery, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.[4]Department of Colorectal Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.江苏省人民医院[5]Department of General Surgery, Chinese General Hospital of People's Liberation Army, Beijing, China.[6]Department of Colorectal Surgery, Fujian Medical University Union Hospital, Fujian, China.[7]Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[8]Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.[9]Department of Unit III &[10]Ostomy Service, Gastrointestinal Cancer Centre, Peking University Cancer Hospital and Institute, Beijing, China.[10]Department of Colorectal Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.[11]Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.首都医科大学宣武医院[12]Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.[13]Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.[14]Department of Gastrointestinal Surgery, The First Hospital of Jilin University, Changchun, China.[15]Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.[16]Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, China.[17]Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention (Ministry of Education), The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.[18]Department of Epidemiology and Statistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China[20]School of Basic Medicine, Peking Union Medical College, Beijing, China.[19]Department of General Surgery, Beijing Friendship Hospital, Capital Medical University and National Clinical Research Centre for Digestive Diseases, Beijing, China.首都医科大学附属北京友谊医院[20]Division of Colorectal Surgery, Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China
第一作者机构:[1]Division of Colorectal Surgery, Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China.
共同第一作者:
通讯作者:
通讯机构:[20]School of Basic Medicine, Peking Union Medical College, Beijing, China.[20]Division of Colorectal Surgery, Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China[*1]Division of Colorectal Surgery, Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
推荐引用方式(GB/T 7714):
Xu Lai,Su Xiangqian,He Zirui,et al.Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial.[J].LANCET ONCOLOGY.2021,22(3):391-401.doi:10.1016/S1470-2045(20)30685-9.
APA:
Xu Lai,Su Xiangqian,He Zirui,Zhang Chenghai,Lu Junyang...&Xiao Yi.(2021).Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial..LANCET ONCOLOGY,22,(3)
MLA:
Xu Lai,et al."Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial.".LANCET ONCOLOGY 22..3(2021):391-401